Competitor News, Product Updates

OM1 ENHANCES GASTROENTEROLOGY CAPABILITIES WITH PREMIUM REAL-WORLD DATASETS FOR ULCERATIVE COLITIS & CROHN’S DISEASE

Available for licensing and analytics, these datasets enable faster access to research-grade IBD condition data, including longitudinal outcomes BOSTON, Sept. 14, 2022 /PRNewswire/ — OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, today announced the launch of its PremiOM™ Ulcerative Colitis (UC) and Crohn’s Disease (CD) datasets,…

Government/Regulatory, Industry News

FDA finalizes guidance on submitting RWD/RWE in application cover letters

To help better track submissions that include real-world data (RWD) and real-world evidence (RWE), the US Food and Drug Administration (FDA) is asking drug and biologics sponsors to indicate the inclusion of such data in their premarket application cover letters. On 8 September, FDA published a final guidance titled, Submitting Documents…

Competitor News, HR

Ovation Announces Ed Stepanski, Ph.D. as General Manager, Data

The new General Manager joins CEO Curt Medeiros to further strengthen Ovation’s executive leadership team September 13, 2022 09:10 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ovation, a next-generation clinicogenomic data company, today announced the appointment of Ed Stepanski, Ph.D., as General Manager, Data. In this new position, Dr. Stepanski will…

Collaborations, Competitor News, Data Partnership

Truveta welcomes four new health system members joining its vision of saving lives with data

TUESDAY SEPTEMBER 13TH, 2022 WellSpan Health, Centura Health, MetroHealth, and Virtua Health join Truveta. Four leading healthcare providers — WellSpan Health, Centura Health, MetroHealth, and Virtua Health — have joined Truveta, the company with a vision of saving lives with data. Together, these new members provide care to patients in…

Collaborations, Competitor News, COVID-19, Product Updates

HHS Technology Group, Datavant, and Mathematica Partner to Combat Chronic Kidney Disease

The nation’s largest COVID-19 Research Database and advanced data-analysis platform to power the early identification of patients at risk of developing chronic kidney disease FORT LAUDERDALE, Fla. and SAN FRANCISCO, Sept. 13, 2022 /PRNewswire/ — HHS Technology Group, LLC™ (HTG); Datavant, the leader in helping organizations securely connect health data; and Mathematica announced today they…

Collaborations, Competitor News

DNAnexus Selected as Platform Provider of the Trusted Research Environment for UK’s Largest Health Research Program

Our Future Health’s trusted research environment will collect information from millions of volunteers and provide tools to transform the prevention, detection, and treatment of diseases September 12, 2022 08:03 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced that it…

Collaborations, Competitor News, Data Partnership, Oncology

Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOne®CDx as a Companion Diagnostic for Relay’s Investigational FGFR2 Inhibitor, RLY-4008

September 12, 2022 06:30 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Today Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, and Relay Therapeutics (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, announced a collaboration to develop FoundationOne®CDx as a companion diagnostic…

Academic, Collaborations, Competitor News

Broad Institute Partners with Datavant to Scale Clinico-Genomic Research by Connecting Health Data

SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) — The Broad Institute of MIT and Harvard (Broad), a leader in advancing human health through genomic research, and Datavant, the leader in helping organizations securely connect health data, today announce a long-term collaboration to scale clinico-genomic registries across rare and common diseases with unmet…